Solitary Fibrous Tumor Treatment Market: Introduction
According to the report, the global solitary fibrous tumor treatment market was valued at US$ 36.5 Mn in 2020 and is projected to expand at a CAGR of 4.5% from 2021 to 2031. Solitary fibrous tumor (SFT) is a rare tumor of mesenchymal origin that accounts for less than 2% of all soft tissue masses. Initially identified in the pleura, SFT has been identified in multiple anatomic locations and can arise anywhere in the body. These tumors occur equally in both men and women, most frequently in the 6th and 7th decades of life.
Improved Diagnostic Procedures to Drive Global Market
In the past few decades, sustained advances through research & technology have led to more reliable methods for differentiating this distinct soft tissue tumor. Advances, specifically in immunohistochemistry and molecular diagnostics, have identified CD34 as the most consistent marker in solitary fibrous tumor. More recently, the discovery of the NAB2-STAT6 fusion gene has led to more precise diagnosis of solitary fibrous tumor. Hence, improvement and new development of diagnostic procedures are anticipated to drive the global solitary fibrous tumor treatment market.
High Cost of Treatment to Hamper Global Market
Several studies have suggested that people with rare diseases face higher healthcare costs than those with common diseases. Solitary fibrous tumor is a very rare disease. Treatment involves surgery and therapies such as radiation therapy and chemotherapy. However, high cost of therapies and other immunotherapies is expected to deter patients from availing these treatments.
Surgery to be Remain Treatment Method
The global solitary fibrous tumor treatment market has been segmented based on treatment and end-user. In terms of treatment, the global solitary fibrous tumor market has been classified into surgery, radiation therapy, and adjuvant chemotherapy. The surgery segment is likely to account for major share of the global market by 2031, due to increase in demand for surgery, as surgical management has been the mainstay treatment for solitary fibrous tumor.
Hospitals to be Key End-user
In terms of end-user, the global solitary fibrous tumor treatment market has been divided into hospitals, ambulatory surgical centers, and others. The hospitals segment is projected to expand at a high CAGR during the forecast period due to rise in patient preference for all types of treatment facility under one roof.
North America to Dominate Global Market
The global solitary fibrous tumor treatment market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global solitary fibrous tumor treatment market in 2020, followed by Europe. North America accounted for major share of the global solitary fibrous tumor treatment market in 2020 due to high awareness and increase in demand for disease risk assessment services for cancer treatment.
The solitary fibrous tumor treatment market in Asia Pacific is projected to expand at a high CAGR from 2021 to 2031. Rise in number of patients, high healthcare expenditure, and geographic expansion by major players, especially in China and India, are anticipated to drive the solitary fibrous tumor treatment market in the region.
The report also presents profiles of leading players in the global solitary fibrous tumor treatment market. These include Pfizer, Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Bayer AG, and Novartis AG.
Global Solitary Fibrous Tumor Treatment Market: Segmentation
- Solitary Fibrous Tumor Treatment Market, by Treatment
- Radiation Therapy
- Adjuvant Chemotherapy
- Solitary Fibrous Tumor Treatment Market, by End-user
- Ambulatory Surgical Clinics
- Solitary Fibrous Tumor Treatment Market, by Region
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
- North America
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
7 of 10 large enterprizes view our Report to take the right decision.View Report